| Completed | Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo Presbyopia | Phase 2 | 2022-12-22 |
| Completed | A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compa Fuchs Endothelial Corneal Dystrophy | Phase 2 | 2022-05-19 |
| Completed | Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2020-12-17 |
| Completed | Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects W Primary Open-angle Glaucoma and Ocular Hypertension | Phase 2 | 2019-01-28 |
| Terminated | LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus Non Infectious Uveitis | Phase 3 | 2018-11-19 |
| Completed | DE-117 Spectrum 5 Study Primary Open-angle Glaucoma and Ocular Hypertension | Phase 3 | 2018-09-27 |
| Completed | A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleat Glaucoma and Ocular Hypertension | Phase 3 | 2018-09-27 |
| Completed | A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleat Glaucoma and Ocular Hypertension | Phase 3 | 2018-09-14 |
| Completed | A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular H Open-angle Glaucoma, Ocular Hypertension | Phase 2 | 2017-07-25 |
| Completed | Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Com Age-Related Macular Degeneration | Phase 2 | 2017-07-05 |
| Completed | A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Ref Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2015-09-16 |
| Completed | A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration Age-Related Macular Degeneration | Phase 2 | 2015-04-01 |
| Completed | A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Int Non-Infectious Uveitis of the Posterior Segment of the Eye | Phase 3 | 2014-09-29 |
| Completed | Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With P Open-angle Glaucoma, Ocular Hypertension | Phase 2 | 2014-06-01 |
| Completed | A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2014-01-01 |
| Completed | Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Op Open-angle Glaucoma or Ocular Hypertension | Phase 2 | 2013-05-01 |
| Completed | A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT Glaucoma and Ocular Hypertension | Phase 1 / Phase 2 | 2012-07-01 |
| Completed | A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients Dry Eye Disease | Phase 2 | 2011-10-01 |
| Completed | Study Assessing Double-masked Uveitis Treatment Uveitis; Posterior, Disorder | Phase 3 | 2011-05-01 |
| Completed | Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension Open-angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | 2011-01-01 |
| Completed | Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease Dry Eye | Phase 2 | 2010-11-01 |
| Completed | Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients Dry Eye | Phase 1 / Phase 2 | 2010-04-01 |
| Completed | A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in P Dry Eye | Phase 2 | 2009-04-01 |
| Completed | Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension Open-Angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | 2009-03-01 |
| Terminated | Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Ag Age-Related Macular Degeneration, Choroidal Neovascularization | Phase 2 | 2008-12-01 |
| Terminated | Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery Corneal Transplantation | Phase 4 | 2008-09-01 |
| Terminated | Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degenerati Age-related Macular Degeneration, Choroidal Neovascularization | Phase 1 / Phase 2 | 2008-09-01 |
| Completed | Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema Diabetic Macular Edema | Phase 2 | 2008-06-01 |
| Completed | Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Compar Healthy | Phase 4 | 2008-05-01 |
| Completed | Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | 2008-03-01 |
| Completed | Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator Cataract | Phase 4 | 2008-02-01 |
| Completed | Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy Diabetic Macular Edema, Diabetic Retinopathy | Phase 1 | 2006-09-01 |